Category: Joint ventures/collaborations
-
Grocery Chain Offering Sites for Cancer Biomarker Trial
The Kroger grocery store chain in the U.S. is establishing a clinical trial network through its urgent care centers, starting with a study of microbiome cancer biomarkers.
-
Damaged Human Lungs Restored for Transplantation
A research team demonstrated the feasibility of connecting anesthetized pigs to human lungs deemed unfit for transplants, for recovering the lungs to transplant quality.
-
Psychedelic Drug Shown to Relieve PTSD Brain Signals
A small clinical trial shows psychotherapy with the psychedelic drug MDMA generates brain signals that help relieve symptoms in people with post-traumatic stress disorder.
-
Biotech, Academic Lab Partner on Microbiome-Safe Products
A biotechnology company creating products for gut health and a university immunology lab are evaluating cleaning products for potential damage to human protective tissues.
-
Nasal Spray Vaccine Shown to Stop Gonorrhea Infections
A vaccine against gonorrhea given as a nasal spray is shown to generate protective immune responses in lab mice of both sexes, and in females similar to an intravaginal vaccine.
-
CEPI Assessing Advanced RNA Nanoparticle Vaccine
An international health organization is evaluating a new type of vaccine made with biodegradable RNA nanoparticles to help head off future viral pandemics.
-
Project to Sequence 20K Dog and Cat Genomes
Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets.
-
BioNTech to Provide Personal Cancer Immunotherapies in UK
The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030.
-
Biotech Alliance Creating Circular RNA Cancer Drug
A partnership of biotechnology components and therapy companies aims to develop new drugs made from circular forms of RNA, starting with a colorectal cancer treatment.
-
Protein Chemistry Biotech Gains Collaboration, Venture Funds
An enterprise discovering new drugs with optical light-based protein chemistry is emerging from stealth, including work with biopharmaceutical company Genentech.